Cronos Group Inc. stock rises Friday, still underperforms market
Shares of Cronos Group Inc. CRON advanced 1.61% to $1.89 Friday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index COMP rising 2.61% to ...
Cronos Group Inc. stock falls Tuesday, underperforms market
Shares of Cronos Group Inc. CRON shed 1.55% to $1.90 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index COMP falling 0.18% to 17,436 ...
This Connecticut city to lose jobs and headquarters after sale of aerospace business
Barnes Group is laying off nearly 30 staff at its Bristol headquarters, which it plans to close, according to a state filing.
Matinas BioPharma Appoints Seasoned Biotech Leaders to Board of Directors
Matinas BioPharma Holdings, Inc. (NYSE American: MTNB) today announced the appointment of biotech industry veterans Keith Murphy and Edward Neugeboren to its Board of Directors as independent members, ...
Cronos Group Inc. to Speak at the 37th Annual Roth Conference
TORONTO, March 10, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein, ...